Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion type Assertion NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_head.
- NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion description "[Moreover, when XPD mutations prevent interaction with the p44 subunit of TFIIH, transactivation directed by certain nuclear receptors is inhibited, regardless of TTD versus XP phenotype, thus explaining the overlapping symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_provenance.
- NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion evidence source_evidence_literature NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_provenance.
- NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion SIO_000772 12820975 NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_provenance.
- NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion wasDerivedFrom befree-20140225 NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_provenance.
- NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_assertion wasGeneratedBy ECO_0000203 NP281616.RAeXRRTqUkFIcZhXW1eT1Ox9AgW7c5nwTfjJdypLxcbUw130_provenance.